World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 14 March 2016
Main ID:  NCT02591992
Date of registration: 27/10/2015
Prospective Registration: No
Primary sponsor: Institute of Cardiology, Warsaw, Poland
Public title: Computed Tomography as the First-Choice Diagnostics in High Pre-Test Probability of Coronary Artery Disease CAT-CAD
Scientific title: Coronary Artery Computed Tomography as the First-Choice Imaging Diagnostics in Patients With High Pre-Test Probability of Coronary Artery Disease
Date of first enrolment: October 2015
Target sample size: 120
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02591992
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic  
Phase:  N/A
Countries of recruitment
Poland
Contacts
Name:     Piotr N Rudzinski, M.D.
Address: 
Telephone: +48608499737
Email: piotr.rudzinski@ikard.pl
Affiliation: 
Name:     Mariusz Kruk, Prof.
Address: 
Telephone:
Email:
Affiliation:  Institute of Cardiology, Warsaw, Poland
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Age >18 years

2. Patients providing written informed consent

3. Indications for elective invasive coronary angiography defined by European Society of
Cardiology as:

- Left ventricle ejection fraction <50% and typical angina symptoms,

- Probability of coronary artery disease due to criteria of age, sex and symptoms
>85%, or

- Probability of coronary artery disease due to criteria of age, sex and symptoms
50-85% with positive or moderate cardiac stress test.

Exclusion Criteria:

1. No Consent to the study

2. Acute coronary syndrome

3. Recurrence of typical angina symptoms 1 year after the last percutaneous coronary
revascularization,

4. Contraindications to invasive coronary angiography

5. GFR <60 ml/min/1.73m2

6. Significant arrhythmia

7. BMI >35 kg/m2



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Coronary Artery Disease
Intervention(s)
Other: Cardiac CT as the first diagnostic modality in suspected CAD
Other: Invasive coronary angiography as indicated by the guidelines
Primary Outcome(s)
The proportion of "avoidable" invasive diagnostic procedures (coronary angiographies not followed by an intervention) in the arm: A. Angio-CT versus B. Classic diagnostics (superiority) [Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
The average number of invasive procedures (coronary angiography/PCI) in the arm: A. Angio - CT versus B. Classic diagnostics (superiority) [Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
Composite outcome of: myocardial infarction, death, acute coronary syndrome, unplanned coronary revascularization, hospitalization for cardiovascular reason, stroke [Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
Secondary Outcome(s)
Average consumption of resources (comparison of coronary artery disease diagnosis and treatment costs in accordance to National Health Service and Institute of Cardiology price lists. [Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
Average time to complete diagnostic and therapeutic cycle (from the first examination of the coronary arteries to termination or disqualification from the surgical treatment). [Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
Number of angioplasty procedures performed in accordance with ESC recommendations where the treatment planned on the basis of CT angiography by an interventional cardiologist is not treated ad-hoc. [Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
Average number of therapeutic procedures (PCI/CABG). [Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
Time to occurrence of composite outcome of: myocardial infarction, death, acute coronary syndrome, unplanned coronary revascularization (including restenosis), urgent hospitalization for cardiovascular reason, stroke [Time Frame: up to 36 months (through study completion)]
Average number of days of hospitalization required to complete the diagnostic and therapeutic cycle. [Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
composite outcome: number of serious adverse events during diagnosis and treatment of coronary artery disease [Time Frame: up to 36 months (through study completion)]
Time to occurrence of composite outcome of: myocardial infarction, death, acute coronary syndrome, unplanned coronary revascularization (including restenosis), urgent hospitalization for cardiovascular reason, stroke [Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
Secondary ID(s)
2.13/III/15
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history